marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-04-2024
Supernus Pharmaceuticals Cash Flow 2011-2024 | SUPN
Annual Cash Flow Supernus Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
117 M | 127 M | 138 M | 143 M | 129 M | 115 M | 66.8 M | 34.5 M | -24.5 M | -57.9 M | -47.2 M | -36.2 M |
Depreciation & Amortization |
85.5 M | 32.6 M | 18.1 M | 6.66 M | 7.06 M | 8.13 M | 2.4 M | 921 K | 928 K | 742 K | 871 K | 879 K |
Accounts Payables |
10.5 M | 9.33 M | 6.15 M | 10.1 M | 3.2 M | 6.84 M | 8.06 M | 4.31 M | 1.86 M | - | - | - |
Accounts Receivables |
165 M | 149 M | 141 M | 87.3 M | 103 M | 65.6 M | 41.5 M | 25.9 M | 17.3 M | 5.05 M | 11 K | - |
Total Inventories |
91.5 M | 86 M | 48.3 M | 26.6 M | 25.7 M | 16.3 M | 16.8 M | 12.6 M | 13.4 M | 7.15 M | 1.15 M | - |
All numbers in USD currency
Quarterly Cash Flow Supernus Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | 38.4 M | - | - | - | 49.1 M | - | 89.3 M | 75.4 M | 4.3 M | - | 78.4 M | 82.5 M | 36.2 M | - | 106 M | 101 M | 8.92 M | - | 99.3 M | 61.7 M | 33 M | - | 96.1 M | 33.7 M | 27.1 M | - | 78.3 M | 39.3 M | 13.4 M | - | 41.9 M | 13.6 M | - | - | - | - | 503 K | - | -30.8 M | -26 M | -19.1 M | - | -48.5 M | -33 M | -17.2 M | - | -31.1 M | -19.8 M | -10.1 M | - | -27.9 M | -18.8 M | -9.8 M |
Depreciation & Amortization |
600 K | 600 K | 20.7 M | - | 600 K | 600 K | 20.6 M | - | 800 K | 700 K | 21.4 M | - | 19.9 M | 13.2 M | 6.59 M | - | 12.6 M | 4.78 M | 1.73 M | - | 5.03 M | 3.36 M | 1.68 M | - | 5.37 M | 3.49 M | 1.71 M | - | 6.46 M | 2.08 M | 741 K | - | 1.73 M | 1.12 M | 429 K | - | 651 K | 431 K | 214 K | - | 701 K | 460 K | 227 K | - | 526 K | 326 K | 162 K | - | 650 K | 438 K | 225 K | - | 651 K | 427 K | 208 K |
Accounts Payables |
6.39 M | 4.63 M | 14.4 M | 1.96 M | 3.39 M | 4.4 M | 11.5 M | 10.5 M | 16 M | 35.5 M | 12.3 M | 9.33 M | 9.12 M | 7.23 M | 5.95 M | 6.15 M | 6.15 M | 6.15 M | 6.15 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 6.84 M | 6.84 M | 6.84 M | 6.84 M | 8.06 M | 8.06 M | 8.06 M | 8.06 M | 4.31 M | 4.31 M | 4.31 M | 4.31 M | 1.86 M | 1.86 M | 1.86 M | 1.86 M | 3.14 M | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
145 M | 152 M | 148 M | 144 M | 142 M | 137 M | 144 M | 165 M | 164 M | 158 M | 145 M | 149 M | 134 M | 137 M | 127 M | 141 M | 141 M | 141 M | 141 M | 87.3 M | 87.3 M | 87.3 M | 87.3 M | 103 M | 103 M | 103 M | 103 M | 65.6 M | 65.6 M | 65.6 M | 65.6 M | 41.5 M | 41.5 M | 41.5 M | 41.5 M | 25.9 M | 25.9 M | 25.9 M | 25.9 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 5.05 M | 5.05 M | 5.05 M | 5.05 M | 11 K | 500 K | - | - | 128 K | - | - | - |
Total Inventories |
64 M | 68.2 M | 75.1 M | 77.4 M | 83.5 M | 90.6 M | 91.1 M | 91.5 M | 83.2 M | 84.9 M | 88.8 M | 86 M | 60.2 M | 58.4 M | 50.2 M | 48.3 M | 48.3 M | 48.3 M | 48.3 M | 26.6 M | 26.6 M | 26.6 M | 26.6 M | 25.7 M | 25.7 M | 25.7 M | 25.7 M | 16.3 M | 16.3 M | 16.3 M | 16.3 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 7.15 M | 7.15 M | 7.15 M | 7.15 M | 1.15 M | 1.15 M | 1.15 M | 1.15 M | - | - | - | - |
All numbers in USD currency